Meeder Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-13,547	Closed	-$39K	–	2518
2020 Q2	$39K	Sell	13,547 -6,215	-31%	-$19.7K	﹤0.01%	978
2020 Q1	$55K	Buy	19,762 +867	+5%	+$2.79K	﹤0.01%	883
2019 Q4	$62K	Buy	+18,895	New	+$54.9K	﹤0.01%	962
2019 Q3	–	Sell	-27,671	Closed	-$87K	–	2371
2019 Q2	$87K	Sell	27,671 -4,082	-13%	-$13.2K	0.01%	794
2019 Q1	$117K	Sell	31,753 -9,895	-24%	-$33.4K	0.01%	660
2018 Q4	$120K	Sell	41,648 -15,702	-27%	-$43.1K	0.01%	596
2018 Q3	$151K	Buy	57,350 +24,925	+77%	+$61.2K	0.01%	551
2018 Q2	$75.9K	Buy	32,425 +22,579	+229%	+$63K	0.01%	676
2018 Q1	$28K	Buy	9,846 +4,133	+72%	+$11.3K	﹤0.01%	809
2017 Q4	$16K	Buy	5,713 +2,251	+65%	+$6.91K	﹤0.01%	1013
2017 Q3	$12K	Hold	3,462	–	–	﹤0.01%	1052
2017 Q2	$9K	Buy	+3,462	New	+$7.96K	﹤0.01%	1046
2016 Q3	–	Sell	-79,817	Closed	-$251K	–	1084
2016 Q2	$251K	Hold	79,817	–	–	0.02%	543
2016 Q1	$266K	Sell	79,817 -40,821	-34%	-$127K	0.03%	529
2015 Q4	$427K	Buy	120,638 +113,840	+1,675%	+$476K	0.04%	381
2015 Q3	$34K	Buy	+6,798	New	+$39K	﹤0.01%	630
2015 Q1	–	Sell	-44,045	Closed	-$339K	–	615
2014 Q4	$339K	Buy	+44,045	New	+$349K	0.04%	356